ANIMAX- nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment United States - English - NLM (National Library of Medicine)

animax- nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment

dechra veterinary products - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), thiostrepton (unii: hr4s203y18) (thiostrepton - unii:hr4s203y18), triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - animax ointment is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs and in anal gland infections in dogs. the preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (candida albicans ) infections. it is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis; and as an adjunct in the treatment of dermatitis due to parasitic infestation.

DERMACOMBIN OINTMENT Israel - English - Ministry of Health

dermacombin ointment

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - ointment - triamcinolone acetonide 1 mg/g; neomycin as sulfate 2.5 mg/g; gramicidin 0.25 mg/g; nystatin 100000 iu/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida

DERMACOMBIN CREAM Israel - English - Ministry of Health

dermacombin cream

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - cream - nystatin 100000 iu/g; gramicidin 0.25 mg/g; neomycin as sulfate 2.5 mg/g; triamcinolone acetonide 1 mg/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida

Panapex Ointment Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

panapex ointment

dechra veterinary products (australia) pty. ltd. - neomycin as the sulfate; nystatin; thiostrepton; triamcinolone acetonide - topical cream, ointment, paste, gel, lotion - neomycin as the sulfate antibiotic active 2.5 mg/ml; nystatin antibiotic active 100000.0 units/ml; thiostrepton antibiotic active 2500.0 units/ml; triamcinolone acetonide steroid-glucocorticoid active 1.0 mg/ml - ear,nose,throat preps.

Oridermyl New Zealand - English - Ministry for Primary Industries

oridermyl

vetoquinol new zealand limited - neomycin sulphate; nystatin; permethrin; triamcinolone acetonide - neomycin sulphate 5.15 g/litre; nystatin 21 g/litre; permethrin 10 g/litre; triamcinolone acetonide 1 g/litre - ectoparasiticide

NEOMYCIN PENICILLIN 100/200 AQUEOUS SUSPENSION FOR INTRAMUSCULAR INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neomycin penicillin 100/200 aqueous suspension for intramuscular injection

intervet australia pty limited - neomycin base (as the sulfate); procaine penicillin - parenteral liquid/solution/suspension - neomycin base (as the sulfate) antibiotic active 100.0 mg/ml; procaine penicillin antibiotic-penicillin active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - actinobacillus pleuropneumoniae (haemoph | actinomyces spp. | antibiotic - anti-infective | clostridia | erysipelothrix spp. | escherichia coli (e. coli) | infections of the urinary tracts | klebsiella spp. | leptospirosis | mastitis | metritis | pasteurella multocida | pasteurella spp. | salmonella | staphylococcus aureus | streptococci | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | escherichia coli | feed efficiency | fowl cholera | fungal infections | girth galls | group d streptococcus | including b-lactamase producin | infections | inflammed pads | itching | keratolytic | klebsiella spp. | l. hardjo | l. interrogans | l. pomona | l. tarassovi | lacerations | mastitis | mycoplasmas | odours | open wou

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC, AND HYDROCORTISONE- neomycin sulfate, polymyxin b sulfate, bacitracin zinc a United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone- neomycin sulfate, polymyxin b sulfate, bacitracin zinc a

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology). the particular anti-infective drugs in this product

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC WITH HYDROCORTISONE ACETATE ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ointment

physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infect

NEOMYCIN, POLYMYXIN B SULFATES AND HYDROCORTISONE suspension United States - English - NLM (National Library of Medicine)

neomycin, polymyxin b sulfates and hydrocortisone suspension

physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 ml - neomycin and polymyxin b sulfates and hydrocortisone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infective drugs in this produ

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE- neomycin sulfate, polymyxin b sulfate and hydrocortisone suspension United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and hydrocortisone- neomycin sulfate, polymyxin b sulfate and hydrocortisone suspension

stat rx usa llc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 ml - neomycin and polymyxin b sulfates and hydrocortisone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infective drugs in this produ